{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:41:24Z","timestamp":1788831684259,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00464-025-11851-w","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T18:24:35Z","timestamp":1752171875000},"page":"6061-6068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bariatric outcomes of high BMI patients with preoperative anti-obesity medications"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4180-1240","authenticated-orcid":false,"given":"Alex D.","family":"Obermark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Young","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"Bernazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse R.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Phillippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhamak","family":"Khorgami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey S.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"5","key":"11851_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/erv.2741","volume":"28","author":"K Bauer","year":"2020","unstructured":"Bauer K, Lau T, Schwille-Kiuntke J et al (2020) Conventional weight loss interventions across the different BMI obesity classes: a systematic review and quantitative comparative analysis. Eur Eat Disord Rev 28(5):492\u2013512. https:\/\/doi.org\/10.1002\/erv.2741","journal-title":"Eur Eat Disord Rev"},{"issue":"6","key":"11851_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000442721","volume":"8","author":"V Yumuk","year":"2015","unstructured":"Yumuk V, Tsigos C, Fried M et al (2015) European guidelines for obesity management in adults. Obes Facts 8(6):402\u2013424. https:\/\/doi.org\/10.1159\/000442721","journal-title":"Obes Facts"},{"issue":"1","key":"11851_CR3","doi-asserted-by":"publisher","first-page":"9521","DOI":"10.1038\/s41598-024-57724-5","volume":"14","author":"LZ Pipek","year":"2024","unstructured":"Pipek LZ, Moraes WAF, Nobetani RM, Cortez VS, Condi AS, Taba JV, Nascimento RFV, Suzuki MO, do Nascimento FS, de Mattos VC, Iuamoto LR, Hsing WT, Carneiro-Dalbuquerque LA, Meyer A, Andraus W (2024) Surgery is associated with better long-term outcomes than pharmacological treatment for obesity: a systematic review and meta-analysis. Sci Rep 14(1):9521. https:\/\/doi.org\/10.1038\/s41598-024-57724-5","journal-title":"Sci Rep"},{"key":"11851_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13098-023-01233-4","volume":"16","author":"W Coutinho","year":"2024","unstructured":"Coutinho W, Halpern B (2024) Pharmacotherapy for obesity: moving towards efficacy improvement. Diabetol Metab Syndr 16:6. https:\/\/doi.org\/10.1186\/s13098-023-01233-4","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"11851_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5534\/wjmh.200010","volume":"39","author":"YJ Tak","year":"2021","unstructured":"Tak YJ, Lee SY (2021) Anti-obesity drugs: long-term efficacy and safety: an updated review. World J Mens Health 39(2):208\u2013221. https:\/\/doi.org\/10.5534\/wjmh.200010","journal-title":"World J Mens Health"},{"key":"11851_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2024.107516","volume":"141","author":"A Malhotra","year":"2024","unstructured":"Malhotra A, Bednarik J, Chakladar S et al (2024) Tirzepatide for the treatment of obstructive sleep apnea: rationale, design, and sample baseline characteristics of the SURMOUNT-OSA phase 3 trial. Contemp Clin Trials 141:107516. https:\/\/doi.org\/10.1016\/j.cct.2024.107516","journal-title":"Contemp Clin Trials"},{"key":"11851_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13643-019-1200-8","volume":"8","author":"I Blazina","year":"2019","unstructured":"Blazina I, Selph S (2019) Diabetes drugs for nonalcoholic fatty liver disease: a systematic review. Syst Rev 8:295. https:\/\/doi.org\/10.1186\/s13643-019-1200-8","journal-title":"Syst Rev"},{"issue":"14","key":"11851_CR8","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","volume":"292","author":"H Buchwald","year":"2004","unstructured":"Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14):1724\u20131737. https:\/\/doi.org\/10.1001\/jama.292.14.1724","journal-title":"JAMA"},{"issue":"8","key":"11851_CR9","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/bjs\/znab245","volume":"108","author":"AGN Robertson","year":"2021","unstructured":"Robertson AGN, Wiggins T, Robertson FP et al (2021) Perioperative mortality in bariatric surgery: meta-analysis. Br J Surg 108(8):892\u2013897. https:\/\/doi.org\/10.1093\/bjs\/znab245","journal-title":"Br J Surg"},{"key":"11851_CR10","doi-asserted-by":"publisher","first-page":"S288","DOI":"10.37765\/ajmc.2022.89292","volume":"28","author":"MA Cornier","year":"2022","unstructured":"Cornier MA (2022) A review of current guidelines for the treatment of obesity. Am J Manag Care 28:S288\u2013S296. https:\/\/doi.org\/10.37765\/ajmc.2022.89292","journal-title":"Am J Manag Care"},{"issue":"10","key":"11851_CR11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/jcph.2487","volume":"64","author":"M Myerson","year":"2024","unstructured":"Myerson M, Paparodis RD (2024) Pharmacotherapy of weight-loss and obesity with a focus on GLP 1-receptor agonists. J Clin Pharmacol 64(10):1204\u20131221. https:\/\/doi.org\/10.1002\/jcph.2487","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"11851_CR12","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1007\/s11695-021-05394-x","volume":"31","author":"AS van Rijswijk","year":"2021","unstructured":"van Rijswijk AS, van Olst N, Schats W, van der Peet DL, van de Laar AW (2021) What is weight loss after bariatric surgery expressed in percentage total weight loss (%TWL)? A systematic review. Obes Surg 31(8):3833\u20133847. https:\/\/doi.org\/10.1007\/s11695-021-05394-x","journal-title":"Obes Surg"},{"issue":"8","key":"11851_CR13","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1007\/s00464-021-08979-w","volume":"36","author":"M Kermansaravi","year":"2022","unstructured":"Kermansaravi M, Lainas P, Shahmiri SS et al (2022) The first survey addressing patients with BMI over 50: a survey of 789 bariatric surgeons. Surg Endosc 36(8):6170\u20136180. https:\/\/doi.org\/10.1007\/s00464-021-08979-w","journal-title":"Surg Endosc"},{"issue":"12","key":"11851_CR14","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.1007\/s00464-023-10387-1","volume":"37","author":"M Ilanga","year":"2023","unstructured":"Ilanga M, Heard JC, McClintic J et al (2023) Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study. Surg Endosc 37(12):9509\u20139513. https:\/\/doi.org\/10.1007\/s00464-023-10387-1","journal-title":"Surg Endosc"},{"issue":"18","key":"11851_CR15","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","volume":"384","author":"JR Lundgren","year":"2021","unstructured":"Lundgren JR, Janus C, Jensen SBK et al (2021) Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med 384(18):1719\u20131730. https:\/\/doi.org\/10.1056\/NEJMoa2028198","journal-title":"N Engl J Med"},{"key":"11851_CR16","doi-asserted-by":"crossref","unstructured":"Ayers KL, Glicksberg BS et al (2018) Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment. J Clin Endocrinol Metab. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7263790\/. Accessed 7 Mar 2025","DOI":"10.1210\/jc.2018-00258"},{"key":"11851_CR17","first-page":"81","volume":"30","author":"H Klein","year":"2024","unstructured":"Klein H (2024) Rising costs lead insurers to drop weight loss drug coverage, further increasing patient Burden. Am J Manag Care 30:81\u201382","journal-title":"Am J Manag Care"},{"issue":"8","key":"11851_CR18","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1007\/s11695-021-05464-0","volume":"31","author":"TC Soong","year":"2021","unstructured":"Soong TC, Lee MH, Lee WJ et al (2021) Long-term efficacy of bariatric surgery for the treatment of super-obesity: comparison of SG, RYGB, and OAGB. Obes Surg 31(8):3391\u20133399. https:\/\/doi.org\/10.1007\/s11695-021-05464-0","journal-title":"Obes Surg"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-11851-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-11851-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-11851-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T18:01:53Z","timestamp":1756922513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-11851-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["11851"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-11851-w","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alex Obermark,\u00a0Da Young Seo,\u00a0Avery Bernazard,\u00a0Dr. Stephen Phillippe and\u00a0Dr. Zhamak Khorgami has no conflicts of interest or financial ties to disclose. Dr. Jesse Richards is on speaker\u2019s bureau for Novo Nordisk, Rhythm Pharmaceuticals, and Eli Lilly. Dr. Geoffrey Chow receives a consulting fee from Fujifilm.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}